The heterogeneity of cirrhosis - systemically assessed endotypes described by fibrosis, apoptosis, and immunoregulatory-related biomarkers
- 1Nordic Bioscience A/S, Herlev Hovedgade 205-207, Herlev, Denmark; Department of Biomedical Sciences, University of Copenhagen, Denmark.
- 2Nordic Bioscience A/S, Herlev Hovedgade 205-207, Herlev, Denmark.
- 3Gastro Unit, Medical Division, University Hospital Hvidovre, Denmark.
- 4Department of Gastroenterology and Hepatology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Copenhagen, Denmark.
- 5Department of Clinical Physiology, Hvidovre Hospital and Faculty of Health Sciences, University of Copenhagen, Denmark; Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Denmark.
- 0Nordic Bioscience A/S, Herlev Hovedgade 205-207, Herlev, Denmark; Department of Biomedical Sciences, University of Copenhagen, Denmark.
|
April 20, 2025
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Biomarkers for fibrogenesis, apoptosis, and inflammation reveal distinct cirrhosis endotypes. These findings may improve patient monitoring and treatment selection for advanced chronic liver disease.
Area Of Science
- Hepatology and Gastroenterology
- Molecular Biology
- Immunology
Background
- Advanced chronic liver disease (cirrhosis) is heterogeneous.
- Identifying distinct cirrhosis endotypes is crucial for personalized patient management.
- Disease activity biomarkers can help classify these endotypes.
Purpose Of The Study
- To investigate cirrhosis endotypes using biomarkers of fibrogenesis, immune cell activity, apoptosis, and systemic inflammation.
- To correlate these biomarkers with disease severity and portal hypertension.
Main Methods
- Plasma samples from 106 cirrhosis patients and 39 controls were analyzed.
- Biomarkers measured included PROC3 (fibrogenesis), GDF-15, CK18 M30 (apoptosis), CRP (inflammation), CPa9-HNE (neutrophil activity), and VICM (macrophage activity).
- Hepatic venous pressure gradient (HVPG) was measured to assess portal hypertension.
Main Results
- Biomarkers for fibrogenesis (PROC3), apoptosis (GDF-15, CK18 M30), and inflammation (CRP) increased with cirrhosis severity and portal hypertension.
- Neutrophil activity (CPa9-HNE) and macrophage activity (VICM) showed inverse correlations with disease severity and portal hypertension.
- Clustering analysis identified four potential cirrhosis endotypes based on these molecular patterns.
Conclusions
- Distinct molecular patterns associated with fibrogenesis, apoptosis, immune activity, and inflammation were observed in cirrhosis patients.
- These patterns suggest the existence of specific cirrhosis endotypes.
- These endotypes could guide future strategies for cirrhosis monitoring, treatment selection, and prognosis.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

